In leukemia, HDAC2 silencing induces modulation of gene expression leading to strong transcriptional activation [50] while in lung cancer, HDAC2 has been proposed to exert an effect on survival by sustaining Mdm2-survivin levels [51]. Here, MDM2 is linked to lung carcinoma.